The Paris Colon Cancer Congress 2026 (P3C), organized by the Young Oncologist in GI Group – Europe, part of the OncoDaily ecosystem, will take place on 10–12 December 2026.

The international congress will bring together colorectal cancer specialists, multidisciplinary care teams, researchers, healthcare professionals, patient advocates, and leaders to advance evidence-based and patient-centered colorectal cancer care.

The programme will address early-onset, localized, and metastatic colorectal cancer, including immunotherapy, biomarkers, treatment sequencing, survivorship, quality of life, equity, access to care, and multidisciplinary decision-making. Through expert sessions, clinical debates, multidisciplinary discussions, and patient perspectives, P3C will provide a platform to examine challenging areas of practice and emerging evidence while supporting practical strategies to improve outcomes worldwide.

Scientific leadership includes Julien Taieb, Annalice Gandini, Amalya Sargsyan, and Francisco Javier Ros.

Register Now.